Form D — Lonestar Medicines, Inc.
0002111460-26-000001 · filed 2026-02-23
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $45,000,000
- Total sold
- $25,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Lonestar Medicines, Inc.
- CIK
- 2111460
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 200 BERKELEY STREET
BOSTON, MA 02116 - Phone
- 518-313-0994
Related persons
-
Stephen Basil Thomas · Executive OfficerBOSTON, MA
-
William Daley Bonificio · Executive OfficerBOSTON, MA
-
Naveen Manu Daryani · Executive OfficerBOSTON, MA
-
Andrew Levin · DirectorBOSTON, MA
-
Gianna Hoffman-Luca · DirectorBOSTON, MA
View original on SEC EDGAR.